Hsbc Holdings PLC Athersys, Inc Transaction History

Hsbc Holdings PLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$0.18 - $0.86 $201 - $964	1,122 Added 0.97%	116,391 $31,000
Q4 2021 Feb 11, 2022	SELL	$0.85 - $1.4 $7,480 - $12,321	-8,801 Reduced 7.09%	115,269 $103,000
Q3 2021 Nov 12, 2021	SELL	$1.33 - $1.77 $3,130 - $4,166	-2,354 Reduced 1.86%	124,070 $168,000
Q2 2021 Aug 13, 2021	BUY	$1.41 - $1.94 $15,694 - $21,594	11,131 Added 9.65%	126,424 $182,000
Q1 2021 May 14, 2021	SELL	$1.61 - $2.77 $5,950 - $10,237	-3,696 Reduced 3.11%	115,293 $207,000
Q4 2020 Feb 12, 2021	BUY	$1.55 - $2.24 $82,729 - $119,557	53,374 Added 81.34%	118,989 $208,000
Q3 2020 Nov 12, 2020	BUY	$1.91 - $3.08 $48,838 - $78,755	25,570 Added 63.85%	65,615 $131,000
Q2 2020 Aug 14, 2020	BUY	$1.97 - $3.98 $78,888 - $159,379	40,045 New	40,045 $111,000

Ticker ATHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 305,110,016
Market Cap $3.05M
Description
Athersys, Inc., a biotechnology company, focuses on the research and development activities in the field of regenerative medicine. Its clinical development programs are focused on treating neurological conditions, cardiovascular diseases, inflammatory and immune disorders, and pulmonary and other conditions. The company's lead platform product i...

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

Stay updated on Hsbc Holdings PLC with notifications on news.